Abstract
Qin-Yun You, Xiao-Bo Zhao, Yan-Ping Shi, Wei Ha
Abstract
Authors
Institutions
No ROR-resolved institution is linked to this work yet.
Provenance
crossref
Confidence 100%
pubmed
Confidence 98%
europepmc
Confidence 96%
unpaywall
Confidence 95%
datacite
Confidence 0%
No local reference links have been materialized yet.
No local citing links have been materialized yet.
Chemistry and biological properties of ascaridole: a systematic review
10.1016/j.fitote.2025.106982 · 2026
Progress of anti-tumor research on natural products combined with doxorubicin
10.1016/j.fitote.2025.107076 · 2026
New species, varieties and combinations from the herbarium and the collections of the Arnold Arboretum
1919
Fengshui forests as a conservation paradigm of the golden larch in China
10.1016/j.foreco.2022.120358 · 2022
Pseudolaric acids: isolation, bioactivity and synthetic studies
10.1039/b906520m · 2010
Some progress on the chemistry of natural bioactive terpenoids form chinese medicinal plants
10.1590/s0074-02761991000600049 · 1991
The cytotoxic principles of pseudolarix kaempferi: pseudolaric acid-a and -B and related Derivatives1
10.1055/s-2006-960989 · 1990
Diterpenoid constituents in Pseudolarix amabilis and their antitumor activities in vitro
2023
Pseudoamaolides a-O, anti-inflammatory triterpene spiroketal lactones from seeds of Pseudolarix amabilis
10.1016/j.bioorg.2022.106180 · 2022
Covalent targeting of PP2A scaffold subunit PPP2R1A by pseudolarolide B enhances holoenzyme assembly to exert anti-inflammatory activity
10.1016/j.bioorg.2026.109684 · 2026
New triterpenoids and PTP1B inhibitory constituents of pseudolarix amabilis
10.1016/j.fitote.2019.104414 · 2019
3,4-secocycloartane triterpenoids from the cones of pseudolarix amabilis
10.1007/s13659-020-00285-7 · 2021
Trisecocycloartane triterpene dilactones from the cones of pseudolarix amabilis
10.1016/j.phytol.2021.08.001 · 2021
New eudesmane-type sesquiterpenoids from the root bark of pseudolarix kaempferi
10.1080/10286020.2015.1117455 · 2015
Inhibition of HL-60 cell growth via cell cycle arrest and apoptosis induction by a cycloartane–labdane heterodimer from Pseudolarix amabilis
10.1039/c5ob02661j · 2016
Pseudolaric acid B ameliorates fungal keratitis progression by suppressing inflammation and reducing fungal load
10.1021/acsinfecdis.2c00536 · 2023
A systematic review of the immune-regulating and anticancer activities of pseudolaric acid B
10.3389/fphar.2017.00394 · 2017
Antifungal evaluation of pseudolaric acid B, a major constituent of pseudolarix kaempferi
10.1021/np50115a007 · 1995
Metabolic pathway and metabolites of pseudolaric acid B
2012
Pseudolaric acid B alleviates non-alcoholic fatty liver disease by targeting PPARα to regulate lipid metabolism and promote mitochondrial biogenesis
10.1007/s11655-025-3832-y · 2025
Gut microbiota-based metabolism contributes to the protection of pseudolaric acid B against MAFLD
10.1016/j.phymed.2025.157235 · 2025
Pseudolaric acid B combats drug-resistant Candida albicans infection via dual-action mechanisms of direct antifungals and vaginal microbiota restoration
2026
Five new diterpenoids from pseudolarix kaempferi
10.1021/np0200010 · 2002
Pseudoamaolide P, a 1,2:3,4:9,10:9,19-tetraseco-cycloartane triterpene spiroketal lactone from seeds of pseudolarix amabilis
10.1080/10286020.2023.2286994 · 2024
HPLC analysis of bioactive diterpenoids from the root bark of Pseudolarix kaempferi
2020
Biosynthesis of the microtubule-destabilizing diterpene pseudolaric acid B from golden larch involves an unusual diterpene synthase
10.1073/pnas.1612901114 · 2017
Late miocene Pseudolarix amabilis bract-scale complex from Zhejiang, East China
10.1371/journal.pone.0180979 · 2017
Assessing the impact of climate change on habitat shifts of typical endemic relict trees in China
2025
A simple method to optimize the HSCCC two-phase solvent system by predicting the partition coefficient for target compound
10.1002/jssc.200700582 · 2008
Application of step-wise gradient high-performance counter-current chromatography for rapid preparative separation and purification of diterpene components from Pseudolarix kaempferi Gordon
10.1016/j.chroma.2012.01.040 · 2012
Total synthesis of pseudolaric acid a
10.1002/anie.200602056 · 2006
Total synthesis of (−)-pseudolaric acid B
10.1021/ja076165q · 2007
Formal synthesis of pseudolaric acid B
10.1055/s-0039-1690829 · 2020
Synthetic studies on pseudolaric acid B: enantioselective synthesis of C4,C10-di-epi-trans-fused [5–7]-bicyclic skeleton
10.1016/j.cclet.2020.09.023 · 2021
Exo-selective intramolecular (4+3) cycloadditions to trans-fused perhydroazulenes: an asymmetric formal synthesis of (−)-pseudolaric acid B
10.1002/anie.202509650 · 2025
Interaction of pseudolaric acid B with the colchicine site of tubulin
10.1016/j.bcp.2012.05.014 · 2012
Structural modification of an angiogenesis inhibitor discovered from traditional Chinese medicine and a structure–activity relationship study
10.1021/jm070906g · 2008
Antifungal diterpenoids of pseudolarix kaempferi, and their structure–activity relationship study
10.1016/s0968-0896(03)00531-5 · 2003
Cytotoxic diterpenoids from the bark of Pseudolarix kaempferi and their structure-activity relationships
10.1021/np060439q · 2007
Design, synthesis, and biological evaluation of pseudolaric acid B derivatives as ferroptosis inducers in colon cancer cells
10.1016/j.bioorg.2025.108852 · 2025
Anticancer effect of terpenes: focus on malignant melanoma
10.1007/s43440-023-00512-1 · doi-reference
Efficacy and safety of pseudolaric acid B against echinococcus multilocularis in vitro and in a murine infection model
10.3389/fmed.2025.1503472 · doi-reference
Pseudolaric acid B inhibits proliferation, invasion and epithelial-to-mesenchymal transition in human pancreatic cancer cell
10.3349/ymj.2018.59.1.20 · doi-reference
Angiogenesis inhibition and cell cycle arrest induced by treatment with pseudolarix acid B alone or combined with 5-fluorouracil
10.1093/abbs/gms029 · doi-reference
Suppressive effect of pseudolaric acid B on Echinococcus multilocularis involving regulation of TGF-β1 signaling in vitro and in vivo
10.3389/fmicb.2022.1008274 · doi-reference
CRGD-modified, pH-sensitive liposomes for co-delivery of docetaxel and ABCG2 siRNA enhance therapeutic efficacy in triple-negative breast cancer
10.1016/j.colsurfb.2026.115616 · doi-reference
Liposomal bupivacaine: effective, cost-effective, or (just) costly?
10.1097/aln.0000000000003658 · doi-reference
Liposomes in cancer therapy: how did we start and where are we now
10.3390/ijms24076615 · doi-reference
Tannic acid-modified silver nanoparticles for antibacterial and anticancer applications
10.1021/acsanm.3c01291 · doi-reference
Supramolecular hybrid hydrogel based on host–guest interaction and its application in drug delivery
10.1021/am505649q · doi-reference
Microemulsion based gel for topical dermal delivery of pseudolaric acid B: in vitro and in vivo evaluation
10.1016/j.ijpharm.2015.07.058 · doi-reference
Modified release and improved stability of unstable BCS II drug by using cyclodextrin complex as carrier to remotely load drug into niosomes
10.1021/acs.molpharmaceut.5b00566 · doi-reference
A comparison report of three advanced methods for drug-cyclodextrin interaction measurements
10.1016/j.jpba.2016.11.037 · doi-reference
Dramatic improvement of the solubility of pseudolaric acid B by cyclodextrin complexation: preparation, characterization and validation
10.1016/j.ijpharm.2015.01.005 · doi-reference
A review on thermal analyses of cyclodextrins and cyclodextrin complexes
10.1007/s10311-018-0806-8 · doi-reference
Synthetic studies on pseudolaric acid B: construction of the trans-fused [5–7] ring system via dieckmann condensation
10.1016/j.tetlet.2018.05.069 · doi-reference
Domino enyne metathesis en route to skeletally diverse, privileged scaffolds: synthesis of the tricyclic core of pseudolaric acid F
10.1039/c9qo00477g · doi-reference
Synthetic studies toward pseudolaric acids: radical cyclization to form bridged scaffold
10.1002/cjoc.202400085 · doi-reference
Development and validation of LC–MS/MS method for quantification of pseudolaric acid B from the root bark of Pseudolarix kaempferi in rat plasma: application to a pharmacokinetic study
10.1016/j.jpba.2015.01.050 · doi-reference
Inhibition of NF-κB and ERK signaling pathways in osteoclasts and M1 macrophage polarization: mechanistic insights into the anti-osteoporotic effects of pseudolaric acid B
10.1016/j.lfs.2024.122592 · doi-reference
Pseudolaric acid B suppresses T lymphocyte activation through inhibition of NF-κB signaling pathway and p38 phosphorylation
10.1002/jcb.22230 · doi-reference
Topical application of pseudolaric acid B improve DNFB-induced contact hypersensitivity via regulating the balance of Th1/Th17/treg cell subsets
10.1016/j.ejps.2012.01.005 · doi-reference
Pseudolaric acid B inhibits T-cell mediated immune response in vivo via p38MAPK signal cascades and PPARγ activation
10.1016/j.lfs.2014.11.020 · doi-reference
Pseudolaric acid B attenuates high salt intake-induced hypertensive left ventricular remodeling by modulating monocyte/macrophage phenotypes
10.12659/msm.932404 · doi-reference
Therapeutic applications of terpenes on inflammatory diseases
10.3389/fphar.2021.704197 · doi-reference
Nonsteroidal anti-inflammatory drug activated gene-1 (NAG-1) modulators from natural products as anti-cancer agents
10.1016/j.lfs.2014.01.075 · doi-reference
Trojan-horse diameter-reducible nanotheranostics for macroscopic/microscopic imaging-monitored chemo-antiangiogenic therapy
10.1021/acsami.1c22350 · doi-reference
Pseudolaric acid B ameliorates synovial inflammation and vessel formation by stabilizing PPARγ to inhibit NF-κB signalling pathway
10.1111/jcmm.16670 · doi-reference
Pseudolaric acid B inhibits angiogenesis and reduces hypoxia-inducible factor 1α by promoting proteasome-mediated degradation
10.1158/1078-0432.ccr-04-0951 · doi-reference
Pseudolarix acid B inhibits angiogenesis by antagonizing the vascular endothelial growth factor-mediated anti-apoptotic effect
10.1016/j.ejphar.2004.07.063 · doi-reference
Pseudolaric acid B inhibits proliferation, invasion, and angiogenesis in esophageal squamous cell carcinoma through regulating CD147
10.2147/dddt.s269915 · doi-reference
Pseudolaric acid B induces G2/M phase arrest in canine mammary tumor cells by targeting CDK1
10.3389/fvets.2025.1644200 · doi-reference
In vitro antimetastatic potential of pseudolaric acid B in HSC-3 human tongue squamous carcinoma cell line
10.1016/j.archoralbio.2024.105940 · doi-reference
mTOR inactivation by ROS-JNK-p53 pathway plays an essential role in psedolaric acid B induced autophagy-dependent senescence in murine fibrosarcoma L929 cells
10.1016/j.ejphar.2013.05.051 · doi-reference
Pseudolaric acid B–induced autophagy contributes to senescence via enhancement of ROS generation and mitochondrial dysfunction in murine fibrosarcoma L929 cells
10.1254/jphs.12269fp · doi-reference
Pseudolaric acid B induces mitotic catastrophe followed by apoptotic cell death in murine fibrosarcoma L929 cells
10.1016/j.ejphar.2012.02.035 · doi-reference
Pseudolaric acid B induced cell cycle arrest, autophagy and senescence in murine fibrosarcoma l929 cell
10.7150/ijms.5726 · doi-reference
Bcl-2 family proteins were involved in pseudolaric acid B–induced autophagy in murine fibrosarcoma L929 cells
10.1254/jphs.08091fp · doi-reference
Pseudolaric acid B induces apoptosis in U937 human leukemia cells via caspase-9-mediated activation of the mitochondrial death pathway
10.3892/mmr.2013.1571 · doi-reference
Pseudolaric acid B induces mitotic arrest and apoptosis in both imatinib-sensitive and -resistant chronic myeloid leukaemia cells
10.1016/j.ejphar.2020.173064 · doi-reference